跳至主要内容
临床试验/NCT04329871
NCT04329871Unknown不适用

An Analysis of Medtronic 670G Insulin Pump Use in Clinical Practice and the Impact on Glycemic Control, Quality of Life, and Compliance

Metabolic Research Institute, Inc.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年3月24日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Glycemic control while using the Medtronic MiniMed 670g system

研究概览

简要总结

Analyze the Medtronic 670g pump on glycemic control

详细描述

An Analysis of the Medtronic 670g Insulin pump use in clinical practice and the impact on glycemic control , quality of life, and compliance

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 or older
  • Documented History of Type 1 Diabetes Mellitus
  • 3 months continuous use of the Medtronic 670g pump system
  • given written informed consent

排除标准

  • Less than 3 months use of the Medtronic 670g pump system
  • Taking any other medication, other than the insulin used in the Medtronic 670g pump, to manage their diabetes
  • having medical conditions or taking medications that would preclude subject involvement or affect the outcomes being measured, in the opinion of the Investigator

结局指标

主要结局

Glycemic control while using the Medtronic MiniMed 670g system

时间窗: through study completion, an average of 1 year.

HbA1c, fructosamine, and glycomark will be compared between the participants last visit on previous insulin therapy and the last visit using the pump

次要结局

  • Efficacy of Quality of Life and satisfaction while using the MiniMed 670g system(through study completion, an average of 1 year)

研究者

发起方
Metabolic Research Institute, Inc.
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验